人 腫瘤壞死因子超家族受體9 蛋白, 組氨酸 標(biāo)簽
產(chǎn)品名稱： 人 腫瘤壞死因子超家族受體9 蛋白, 組氨酸 標(biāo)簽
英文名稱： Human 4-1BB Protein, His Tag
產(chǎn)品編號(hào)： 41B-H52H3
產(chǎn)品價(jià)格： 24255
產(chǎn)品產(chǎn)地： 中國
品牌商標(biāo)： 北京百普賽斯生物科技股份有限公司
更新時(shí)間： 2025-09-19T18:06:11
使用范圍： null
| 規(guī)格 | 價(jià)格 |
| 1mg |
- 聯(lián)系人 : 團(tuán)子
- 地址 : 北京經(jīng)濟(jì)技術(shù)開發(fā)區(qū)宏達(dá)北路8號(hào)5號(hào)樓4層
- 郵編 : 100176
- 所在區(qū)域 : 北京
- 電話 : 151****8562 點(diǎn)擊查看
- 傳真 : 點(diǎn)擊查看
- 郵箱 : order.cn@acrobiosystems.com
- 二維碼 : 點(diǎn)擊查看
4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.